Caring for Love

Since 2002, Sinocare has been dedicated to driving changes in the field of blood glucose monitoring with love and technology, and improving the lives of diabetes patients.

  • 2002

    Sinocare was founded

  • 2008

    Approved by NDRC(National Development and Reform Commission) as“Biomedical Engineering Model Project”

  • 2012

    Listed on SZSE (Shenzhen Stock Exchange)

  • 2013

    To be the leading BGMS manufacturer in Asia

  • 2014

    Acquired Beijing Jianheng Diabetes Clinic

  • 2016

    Acquisition of largest US based BGM manufacturer Nipro Diagnostic Inc.(Now renamed as Trividia Health Inc.)

    Acquired PTS Diagnostics Inc

  • 2017

    Hospital diabetes management system put into use

  • 2018

    Awarded “ 2018 China Best Employer Enterprises Award”

  • 2019

    AGEscan, a non-invasive diabetes risk screening product, opening a new entrance to the whole course management of diabetes

  • 2020

    iPOCT standardization laboratory is marketed officially in CMEF Shanghai

  • 2021

    The groundbreaking ceremony of sinocare iPOCT industrial park project is held

  • 2022

    iPOCT Industrial Park was Put into Use

  • 2023

    The continuous glucose monitoring (CGMS) product officially obtained the product registration certificate